SEC Form 4 · accession 0001209191-15-065352
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell J. Cox
Officer — EVP & Chief Commercial Officer
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Aug 7, 2015 | F | 978 | $181.79 | D | 63,667 | D | |
| Ordinary Shares | Aug 10, 2015 | F | 4,565 | $181.48 | D | 59,102 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2Includes 92 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.